Innovations can help India's biotechnology economy to hit $100B by 2025: Amitabh Kant

By Press Trust of India|27th Jul 2020
Niti Aayog CEO Kant said India has established biotechnology parks and incubators across the country to facilitate scientists and MSMEs with technology demonstration, along with pilot studies for accelerated commercial development.
Clap Icon0 claps
  • +0
    Clap Icon
Share on
close
Clap Icon0 claps
  • +0
    Clap Icon
Share on
close
Share on
close

The Indian biotechnology space has the potential to grow to $100 billion in size by 2025 on the back of innovations in bio-manufacturing technologies, Niti Aayog CEO Amitabh Kant said on Friday.


Addressing a webinar titled 'Global Perspective on India's Biotech Potential: Manufacturing Hub & Foreign Investment', Kant said India is working to boost the biotechnology sector under its flagship programmes like 'Make in India' and 'Startup India'.


"India's biotechnology economy can approach $100 billion in 2025 if the right policies are put in place, giving industry the required stimulation," he said.
Amitabh Kant, CEO NITI Aayog

Amitabh Kant, CEO, Niti Aayog




Kant said India has established biotechnology parks and incubators across the country to facilitate scientists and MSMEs with technology demonstration, along with pilot studies for accelerated commercial development.


Noting that an increase in the number of biotech incubators can boost research and promote the growth of startups, Kant said, "Innovations in bio-manufacturing technologies are critical for the success of the Indian biotech industry."


In another development, Kant said real-time data would be key in fighting the coronavirus as it helps in contact tracing, which is essential for preventing further spread of the disease.


Speaking at India Policy Forum 2020, organised by NCAER, on Friday, Kant said the government should actively put data in the public domain as debates and discussions would help in taking the right policy decisions.


"Data on a real-time basis is very critical. We have been working for the last year-and-half, and our experience is that real-time data is really the key. In the time of coronavirus, this becomes even more important...My belief is that it will be very difficult to handle COVID-19 without huge amounts of increased testing and without contact tracing," he said.


Stating that the government should actively put out data before the public and academics, the Niti Aayog CEO said: "that is the only way we will be able to make right policy decisions".



(Disclaimer: Additional background information has been added to this PTI copy for context)


Edited by Megha Reddy

Get access to select LIVE keynotes and exhibits at TechSparks 2020. In the 11th edition of TechSparks, we bring you best from the startup world to help you scale & succeed. Join now! #TechSparksFromHome

Clap Icon0 Shares
  • +0
    Clap Icon
Share on
close
Clap Icon0 Shares
  • +0
    Clap Icon
Share on
close
Share on
close